BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11847033)

  • 1. [Update on differenciated thyroid carcinoma].
    Karayan L; Hadjadj S; Larsen CJ; Maréchaud R; Kraimps JL
    Bull Cancer; 2002 Jan; 89(1):113-23. PubMed ID: 11847033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular basis of tumors arising in thyroid follicular cells].
    Wynford-Thomas D
    Ann Chir; 1999; 53(3):237-43. PubMed ID: 10339867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic mutations in thyroid carcinoma.
    Taccaliti A; Boscaro M
    Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic molecular biology in solid tumors--thyroid gland].
    Faksvåg Haugen DR; Varhaug JE; Akslen LA; Lillehaug JR
    Tidsskr Nor Laegeforen; 1998 May; 118(14):2199-203. PubMed ID: 9656818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular crossroads in thyroid tumorigenesis. Molecular genetics of human thyroid neoplasms.
    Thomas G
    Hum Exp Toxicol; 1994 Oct; 13(10):717-8. PubMed ID: 7826689
    [No Abstract]   [Full Text] [Related]  

  • 6. Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas.
    Pallante P; Visone R; Croce CM; Fusco A
    Endocr Relat Cancer; 2010 Mar; 17(1):F91-104. PubMed ID: 19942715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays.
    Zhao J; Leonard C; Brunner E; Gemsenjäger E; Heitz PU; Odermatt B
    Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathogenesis of follicular cell derived thyroid cancers.
    Parameswaran R; Brooks S; Sadler GP
    Int J Surg; 2010; 8(3):186-93. PubMed ID: 20097316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular thyroid lesions, elements that affect both diagnosis and prognosis.
    Zeiger MA; Dackiw AP
    J Surg Oncol; 2005 Mar; 89(3):108-13. PubMed ID: 15719377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Familial nonmedullary thyroid cancer].
    Sugino K; Mimura T; Ito K; Ito K
    Nihon Rinsho; 2000 Jul; 58(7):1519-22. PubMed ID: 10921335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.
    Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S
    J Pathol; 2008 May; 215(1):87-96. PubMed ID: 18306168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
    Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
    Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biology of thyroid neoplasms.
    Satta MA; Nanni S; Della Casa S; Pontecorvi A
    Rays; 2000; 25(2):151-61. PubMed ID: 11370534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Loss of heterozygosity on chromosome 3p in thyroid tumors].
    Hu MJ; Xu HD; Zhou R; Li XF; Zhang HY
    Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):305-8. PubMed ID: 18956647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the cell death-inducing gene bax in carcinomas developed from the follicular cells of the thyroid gland.
    Branet F; Brousset P; Krajewski S; Schlaifer D; Selves J; Reed JC; Caron P
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2726-30. PubMed ID: 8675602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer.
    Weber KB; Shroyer KR; Heinz DE; Nawaz S; Said MS; Haugen BR
    Am J Clin Pathol; 2004 Oct; 122(4):524-31. PubMed ID: 15487449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid cancer yield in patients with Graves' disease.
    Stocker DJ; Burch HB
    Minerva Endocrinol; 2003 Sep; 28(3):205-12. PubMed ID: 14605602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating thyroid cancer markers.
    Gupta M; Chia SY
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):383-8. PubMed ID: 17940468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal aberrations in thyroid follicular-cell neoplasia: in the search of novel oncogenes and tumour suppressor genes.
    Zitzelsberger H; Thomas G; Unger K
    Mol Cell Endocrinol; 2010 May; 321(1):57-66. PubMed ID: 19961897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of the class II tumor suppressor gene maspin in thyroid carcinogenesis].
    Boltze C; Hoang-Vu C; Schneider-Stock R; Lehnert H; Roessner A
    Verh Dtsch Ges Pathol; 2004; 88():237-45. PubMed ID: 16892558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.